2023 - Research.com Medicine in United States Leader Award
2022 - Research.com Best Scientist Award
2012 - Libin/AHFMR Prize in Cardiovascular Research
2004 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
His primary scientific interests are in Internal medicine, Myocardial infarction, Cardiology, Surgery and Angioplasty. Percutaneous coronary intervention, Randomized controlled trial, Stroke, Aspirin and Unstable angina are the subjects of his Internal medicine studies. His Myocardial infarction research integrates issues from Coronary artery disease and Anesthesia.
His study brings together the fields of Mortality rate and Cardiology. The Surgery study combines topics in areas such as Gastroenterology, Placebo and Tissue plasminogen activator. In his study, Pathology is strongly linked to Restenosis, which falls under the umbrella field of Angioplasty.
Eric J. Topol mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Surgery and Angioplasty. Internal medicine is a component of his Percutaneous coronary intervention, Revascularization, Coronary artery disease, Abciximab and Unstable angina studies. His Cardiology research includes elements of Restenosis and Percutaneous.
Eric J. Topol focuses mostly in the field of Myocardial infarction, narrowing it down to matters related to Randomized controlled trial and, in some cases, Clinical trial. Eric J. Topol frequently studies issues relating to Placebo and Surgery. His Angioplasty research includes elements of Artery, Bypass surgery, Balloon and Atherectomy.
Eric J. Topol mainly investigates Internal medicine, MEDLINE, Health care, Genetics and Cardiology. His Surgery research extends to Internal medicine, which is thematically connected. Eric J. Topol regularly links together related areas like Bioinformatics in his MEDLINE studies.
The Genetics study which covers Disease that intersects with Clinical psychology. His Cardiology research is mostly focused on the topic Myocardial infarction. Myocardial infarction is closely attributed to Pathology in his research.
Health care, MEDLINE, Personalized medicine, Genetic testing and Internal medicine are his primary areas of study. His Health care study also includes fields such as
His research in Personalized medicine intersects with topics in Test and Genome-wide association study. His work deals with themes such as CYP2C19 and Cardiology, which intersect with Internal medicine. His Clopidogrel research entails a greater understanding of Myocardial infarction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
Maarten Simoons;Eric Topol;Robert Califf;Frans van de Werf.
The New England Journal of Medicine (1993)
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger.
The New England Journal of Medicine (2006)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
Steven R. Steinhubl;Peter B. Berger;J. Tift Mann;Edward T. A. Fry.
Risk of cardiovascular events associated with selective COX-2 inhibitors.
D Mukherjee;S.E Nissen;E.J Topol.
Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.
Daniel P. Oran;Eric J. Topol.
Annals of Internal Medicine (2020)
High-performance medicine: the convergence of human and artificial intelligence
Eric J. Topol.
Nature Medicine (2019)
Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Umesh N. Khot;Monica B. Khot;Christopher T. Bajzer;Shelly K. Sapp.
Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial
Steven E. Nissen;E. Murat Tuzcu;Peter Libby;Peter Libby;Paul D. Thompson.
Our Preoccupation With Coronary Luminology The Dissociation Between Clinical and Angiographic Findings in Ischemic Heart Disease
Eric J. Topol;Steven E. Nissen.
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.
Arman T Askari;Samuel Unzek;Zoran B Popovic;Corey K Goldman.
The Lancet (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: